Table 2. Prevalence of MS components in the study subjects and their effects on the likelihood of having MS.
| Component of metabolic syndrome | Total prevalence (n=823) | Normal (n=634) | MS (n=189) | p-value | OR (95% CI) |
|---|---|---|---|---|---|
| Fasting TG ≥150 mg/dL | 204 (25.0) | 119 (18.9) | 85 (45.7) | <0.001 | 3.61 (2.54~5.13) |
| Fasting blood glucose ≥110 mg/dL | 169 (20.6) | 66 (10.5) | 103 (54.5) | <0.001 | 4.6 (3.6~5.8) |
| Fasting HDL cholesterol <40 mg/dL | 280 (34.3) | 186 (29.5) | 94 (50.5) | <0.001 | 2.43 (1.74~3.41) |
| High blood pressure ≥130/85 mmHg | 227 (27.6) | 92 (14.5) | 135 (71.4) | <0.001 | 2.24 (1.9~2.63) |
| Waist circumference >102 cm | 279 (33.9) | 111 (17.5) | 168 (88.9) | <0.001 | 2.47 (2.1~2.79) |
| Fasting total cholesterol ≥240 mg/dL | 93 (11.4) | 62 (9.8) | 31 (16.7) | 0.009 | 1.8 (1.14~2.92) |
| Fasting LDL cholesterol ≥160 mg/dL | 76 (9.6) | 49 (8.0) | 27 (15.2) | 0.005 | 2.05 (1.2~3.4) |
| Affected by dyslipidemia | 409 (51.8) | 275 (44.9) | 134 (75.3) | <0.001 | 3.73 (2.56~5.43) |
Values are presented as number (%).
MS: metabolic syndrome, OR: odds ratio, CI: confidence interval, TG: triglycerides, HDL: high-density lipoprotein, LDL: low-density lipoprotein.